Lipide: Diagnostik und Therapie bei Diabetes mellitus (Update 2023)

Hyper- and dyslipidemia contribute to cardiovascular morbidity and mortality in diabetic patients. Pharmacological therapy to lower LDL cholesterol has convincingly shown to reduce cardiovascular risk in diabetic patients. The present article represents the recommendations of the Austrian Diabetes A...

Descripción completa

Detalles Bibliográficos
Autores principales: Wascher, Thomas C., Paulweber, Bernhard, Toplak, Hermann, Saely, Christoph H., Drexel, Heinz, Föger, Bernhard, Hoppichler, Friedrich, Stulnig, Thomas, Stingl, Harald, Clodi, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Leitlinien Für Die Praxis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133339/
https://www.ncbi.nlm.nih.gov/pubmed/37101037
http://dx.doi.org/10.1007/s00508-023-02166-8
Descripción
Sumario:Hyper- and dyslipidemia contribute to cardiovascular morbidity and mortality in diabetic patients. Pharmacological therapy to lower LDL cholesterol has convincingly shown to reduce cardiovascular risk in diabetic patients. The present article represents the recommendations of the Austrian Diabetes Association for the use of lipid-lowering drugs in diabetic patients according to current scientific evidence.

Ejemplares similares